DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-4.53%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$99.1M
AUM Growth
+$99.1M
(-6%)
Cap. Flow
+$6.84M
Cap. Flow
% of AUM
6.9%
Top 10 Holdings %
Top 10 Hldgs %
58.86%
Holding
65
New
16
Increased
6
Reduced
8
Closed
6
Top Buys
| 1 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$3.9M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$3.01M |
| 3 |
OCRX
Ocera Therapeutics, Inc.
OCRX
|
$2.52M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$1.67M |
| 5 |
Neurocrine Biosciences
NBIX
|
$1.04M |
Top Sells
| 1 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
$4.42M |
| 2 |
VXRT
Vaxart
VXRT
|
$2.08M |
| 3 |
Arcturus Therapeutics
ARCT
|
$1.47M |
| 4 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$1.42M |
| 5 |
Galmed Pharmaceuticals
GLMD
|
$766K |
Sector Composition
| 1 | Healthcare | 55.18% |
| 2 | Financials | 1.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEMI
51
DELISTED
Chembio diagnostics, Inc.
CEMI
| $205K | 0.21% |
55,202
| – | – |
|
52
Tonix Pharmaceuticals
TNXP
$247M
| $171K | 0.17% |
25,000
| – | – |
|
53
InspireMD
NSPR
$100M
| $140K | 0.14% |
63,700
-20,526
| -24% | -$45.1K |
|
|
GBIM
54
DELISTED
GLOBEIMMUNE INC COM STK (DE)
GBIM
| $74K | 0.07% |
+10,745
| New | +$74K |
|
55
Retractable Technologies
RVP
$24.2M
| $58K | 0.06% |
20,000
| – | – |
|
|
TBRA
56
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| – | – |
-30,000
| Closed | -$204K |
|
|
NWBO
57
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| – | – |
-12,017
| Closed | -$81K |
|
|
58
Arcturus Therapeutics
ARCT
$479M
| – | – |
-84,996
| Closed | -$1.47M |
|
59
Ardelyx
ARDX
$1.56B
| – | – |
-25,000
| Closed | -$399K |
|
|
VXRT
60
DELISTED
Vaxart
VXRT
| – | – |
-729,781
| Closed | -$2.08M |
|
|
KERX
61
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| – | – |
-92,400
| Closed | -$1.42M |
|